| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.584 | 42.301 | 45.195 | 62.995 | 59.803 | 61.054 | 101.307 | 175.040 | 194.660 | 206.768 |
| Total Income - EUR | 19.781 | 42.929 | 45.956 | 63.902 | 63.243 | 64.765 | 103.424 | 178.246 | 199.367 | 223.041 |
| Total Expenses - EUR | 15.024 | 34.501 | 39.146 | 51.197 | 46.123 | 40.763 | 67.054 | 106.122 | 116.933 | 126.903 |
| Gross Profit/Loss - EUR | 4.758 | 8.427 | 6.810 | 12.705 | 17.119 | 24.002 | 36.370 | 72.124 | 82.434 | 96.138 |
| Net Profit/Loss - EUR | 4.164 | 7.998 | 6.351 | 12.066 | 16.487 | 23.588 | 35.597 | 70.599 | 80.739 | 90.972 |
| Employees | 2 | 2 | 3 | 4 | 3 | 2 | 2 | 3 | 4 | 3 |
Check the financial reports for the company - Bio Oculus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.692 | 2.817 | 0 | 0 | 3.958 | 3.335 | 39.132 | 33.046 | 29.296 | 23.143 |
| Current Assets | 7.861 | 16.237 | 26.173 | 37.557 | 47.918 | 69.734 | 111.031 | 186.305 | 242.914 | 217.581 |
| Inventories | 6.085 | 8.813 | 16.968 | 21.446 | 29.569 | 26.717 | 28.512 | 54.118 | 64.585 | 80.268 |
| Receivables | 588 | 0 | 0 | 133 | 1.480 | 1.311 | 8.876 | 1.354 | 3.627 | 2.488 |
| Cash | 1.189 | 7.423 | 9.205 | 15.978 | 16.870 | 41.706 | 73.643 | 130.832 | 174.701 | 134.826 |
| Shareholders Funds | 9.404 | 17.306 | 23.364 | 34.401 | 50.222 | 71.031 | 104.057 | 176.628 | 256.832 | 219.630 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.789 | 2.380 | 2.808 | 3.156 | 1.654 | 2.038 | 59.993 | 56.109 | 29.935 | 33.852 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Bio Oculus Srl